{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:31:16Z","timestamp":1793701876786,"version":"4.5.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Immune cells have been implicated in interstitial lung diseases (ILDs), although their phenotypes and effector mechanisms remain poorly understood. To better understand these cells, we conducted an exploratory mass cytometry analysis of immune cell subsets in bronchoalveolar lavage fluid (BALF) from patients with idiopathic pulmonary fibrosis (IPF), connective-tissue disease (CTD)-related ILD, and sarcoidosis, using two panels including 64 markers. Among myeloid cells, we observed the expansion of CD14\n                    <jats:sup>+<\/jats:sup>\n                    CD36\n                    <jats:sup>hi<\/jats:sup>\n                    CD84\n                    <jats:sup>hi<\/jats:sup>\n                    CCR2\n                    <jats:sup>\u2013<\/jats:sup>\n                    monocyte populations in IPF. These CD14\n                    <jats:sup>+<\/jats:sup>\n                    CD36\n                    <jats:sup>hi<\/jats:sup>\n                    CD84\n                    <jats:sup>hi<\/jats:sup>\n                    CCR2\n                    <jats:sup>\u2013<\/jats:sup>\n                    subsets were also increased in ILDs with a progressive phenotype, particularly in a case of acute exacerbation (AEx) of IPF. Analysis of B cells revealed the presence of cells at various stages of differentiation in BALF, with a higher percentage of IgG memory B cells in CTD-ILDs and a trend toward more FCRL5\n                    <jats:sup>+<\/jats:sup>\n                    B cells. These FCRL5\n                    <jats:sup>+<\/jats:sup>\n                    B cells were also present in the patient with AEx-IPF and sarcoidosis with advanced lung lesions. Among T cells, we found increased levels of IL-2R\n                    <jats:sup>+<\/jats:sup>\n                    TIGIT\n                    <jats:sup>+<\/jats:sup>\n                    LAG3\n                    <jats:sup>+<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in IPF, increased levels of CXCR3\n                    <jats:sup>+<\/jats:sup>\n                    CD226\n                    <jats:sup>+<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in sarcoidosis, and increased levels of PD1\n                    <jats:sup>+<\/jats:sup>\n                    TIGIT\n                    <jats:sup>+<\/jats:sup>\n                    CD57\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells in CTD-ILDs. Together, these findings underscore the diverse immunopathogenesis of ILDs.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2023.1145814","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T01:32:50Z","timestamp":1678066370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Kentaro","family":"Hata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoshi","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Kunimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01504-2015","article-title":"Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada","volume":"48","author":"Hopkins","year":"2016","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.149","article-title":"Interstitial lung disease in connective tissue disease\u2013mechanisms and management","volume":"10","author":"Wells","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"190029","DOI":"10.1183\/16000617.0029-2019","article-title":"What have we learned from basic science studies on idiopathic pulmonary fibrosis","volume":"28","author":"Yanagihara","year":"2019","journal-title":"Eur Respir Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1165\/rcmb.2021-0418oc","article-title":"Multi-platform single-cell analysis identifies immune cell types enhanced in pulmonary fibrosis","volume":"67","author":"Serezani","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000698","article-title":"Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases","volume":"26","author":"Yanagihara","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302269","article-title":"In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: Implications for understanding lung disease in humans","volume":"192","author":"Cai","year":"2014","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature20611","article-title":"Identification of an atypical monocyte and committed progenitor involved in fibrosis","volume":"541","author":"Satoh","year":"2017","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1900646","DOI":"10.1183\/13993003.00646-2019","article-title":"A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by m-CSF\/M-CSFR signalling in monocyte-derived alveolar macrophages","volume":"55","author":"Joshi","year":"2020","journal-title":"Eur Respir J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e136180","DOI":"10.1172\/jci.insight.136180","article-title":"Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"5","author":"Owczarczyk","year":"2020","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector b cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ b cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.155","article-title":"Mass cytometry analysis of immune cells in the brain","volume":"13","author":"Korin","year":"2018","journal-title":"Nat Protoc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Statement on sarcoidosis. joint statement of the American thoracic society (ATS), the European respiratory society (ERS) and the world association of sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS board of directors and by the ER","volume":"160","author":"Hunninghake","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis an international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European respiratory Society\/American thoracic society research statement: Interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1900161","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"54","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.04.094","article-title":"DOCK8 deficiency causes a skewing to type 2 immunity in the gut with expansion of group 2 innate lymphoid cells","volume":"559","author":"Matsubara","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408792111","article-title":"Automated identification of stratifying signatures in cellular subpopulations","volume":"111","author":"Bruggner","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.04.425268","article-title":"Single cell RNA-seq and mass cytometry reveals a novel and a targetable population of macrophages in idiopathic pulmonary fibrosis","volume":"2021","author":"Ayaub","year":"2021","journal-title":"bioRxiv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1189\/jlb.0211096","article-title":"Fc receptor-like 5 promotes b cell proliferation and drives the development of cells displaying switched isotypes","volume":"91","author":"Dement-Brown","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-022-00305-9","article-title":"Excessive IL-15 promotes cytotoxic CD4 + CD28\u2013 T cell-mediated renal injury in lupus nephritis","volume":"19","author":"Zhang","year":"2022","journal-title":"Immun Ageing"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.41554","article-title":"Distinct expression of coinhibitory molecules on alveolar T cells in patients with rheumatoid arthritis\u2013associated and idiopathic inflammatory myopathy\u2013associated interstitial lung disease","volume":"73","author":"Nakazawa","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa412","article-title":"Immune-checkpoint kinetics for T cells in anti-MDA5 positive interstitial lung disease","volume":"60","author":"Suzuki","year":"2021","journal-title":"Rheumatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.10.017","article-title":"CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders","volume":"204","author":"Cuenca","year":"2019","journal-title":"Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201808-1560OC","article-title":"Role of B7H3\/IL-33 signaling in pulmonary fibrosis\u2013induced profibrogenic alterations in bone marrow","volume":"200","author":"Nakashima","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00256.2011","article-title":"A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury","volume":"302","author":"Liang","year":"2012","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.07.013","article-title":"Reduced supply of monocyte-derived macrophages leads to a transition from nodular to diffuse lesions and tissue cell activation in silica-induced pulmonary fibrosis in mice","volume":"185","author":"Shichino","year":"2015","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","article-title":"Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: A retrospective, multicentre cohort study","volume":"7","author":"Scott","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14728222.2018.1472768","article-title":"Update on fc receptor-like (FCRL) family: New immunoregulatory players in health and diseases","volume":"22","author":"Rostamzadeh","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3002432","article-title":"A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis","volume":"3","author":"Owczarczyk","year":"2011","journal-title":"Sci Transl Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.631134","article-title":"Variants of novel immunomodulatory fc receptor like 5 gene are associated with multiple sclerosis susceptibility in the polish population","volume":"12","author":"Chorazy","year":"2021","journal-title":"Front Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2213-2600(22)00359-9","article-title":"Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): A double-blind, double-dummy, randomised, controlled, phase 2b trial","volume":"11","author":"Maher","year":"2023","journal-title":"Lancet Respir Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-017-0653-3","article-title":"Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis","volume":"18","author":"Hou","year":"2017","journal-title":"Respir Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106443","article-title":"Regulatory T cells are a double-edged sword in pulmonary fibrosis","volume":"84","author":"Wang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa022","article-title":"Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease","volume":"32","author":"Suzuki","year":"2020","journal-title":"Int Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3146-z","article-title":"Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia\/lymphoma","volume":"97","author":"Yanagihara","year":"2018","journal-title":"Ann Hematol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00157508","article-title":"CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis","volume":"34","author":"Busuttil","year":"2009","journal-title":"Eur Respir J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab085","article-title":"DNAM-1 versus TIGIT: Competitive roles in tumor immunity and inflammatory responses","volume":"33","author":"Shibuya","year":"2021","journal-title":"Int Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0052144","article-title":"CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis","volume":"8","author":"Batista","year":"2013","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3233\/DMA-2011-0847","article-title":"Immunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-\u03b3 responses in HIV patients responding stably to ART","volume":"31","author":"Fernandez","year":"2011","journal-title":"Dis Markers"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.12.8415","article-title":"Functional and phenotypic characterization of CD57 + CD4 + T cells and their association with hiv-1-induced t cell dysfunction","volume":"175","author":"Palmer","year":"2005","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120555","article-title":"Autoreactive T effector memory differentiation mirrors \u03b2 cell function in type 1 diabetes","volume":"128","author":"Yeo","year":"2018","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1145814\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T01:32:54Z","timestamp":1678066374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1145814\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2023.1145814"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1145814","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.12.523734","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"article-number":"1145814"}}